Chase Dave

TwitterFacebook
Get flash to fully experience Pearltrees

Patients Are More Than A Vessel For Billing Codes

http://techcrunch.com/2012/03/29/patients-are-more-than-a-vessel-for-billing-codes/ Editor’s note: This guest post was written by Dave Chase , the CEO of Avado.com , a patient portal & relationship management company that was a TechCrunch Disrupt finalist . Previously he was a management consultant for Accenture’s healthcare practice and founder of Microsoft’s Health platform business. You can follow him on Twitter @chasedave . It will be virtually impossible to succeed in the new reimbursement model without recognizing what has long been said, but little done about it — “the most important member of the care team is the patient.” Having implemented or reviewed over 100 health IT systems, there is one common purpose at the core of the architecture of these systems — how to get as big a bill out as quickly as possible.
https://avado.com/newsroom/aetna-scaring-its-competition-and-delighting-startups

Aetna: Scaring Its Competition and Delighting Startups | Avado - Connecting Providers and Patients

This article was also published on TechCrunch . Wither health insurance? A former medical advisor to the Obama Administration who also is the brother of former Presidential Chief of Staff predicted in the New York Times that by 2020 health insurance companies will be extinct. Nearly two years ago, I penned a piece entitled Health Insurance's Bunker Buster .
The insurance middleman has taken a toll on the family doctor. New practice models plan to change that. Physicians in Seattle, Silicon Valley and Boston are proving what the rest of the world already knows. When you have a high function primary care system , there’s less money spent and better health outcomes. Before House, M.D., there was Marcus Welby, M.D. who epitomized the glory days of healthcare. Dr.

Direct primary care and the Marcus Welby vision of primary care

http://www.kevinmd.com/blog/2011/05/direct-primary-care-marcus-welby-vision-primary-care.html
Editor’s note: This guest post was written by Dave Chase , the CEO of Avado.com , a patient portal & relationship management company that was a TechCrunch Disrupt finalist . Previously he was a management consultant for Accenture’s healthcare practice and founder of Microsoft’s Health platform business. You can follow him on Twitter @chasedave . Image is courtesy of Wikimedia Commons. http://techcrunch.com/2012/02/02/why-its-good-news-healthit-is-so-bad/

Why It’s Good News HealthIT is So Bad

The Most Important Organization In Silicon Valley That No One Has Heard About

Editor’s note: This guest post was written by Dave Chase, the CEO of Avado.com , a health technology company that was a TechCrunch Disrupt finalist . Previously he was a management consultant for Accenture’s healthcare practice and was the founder of Microsoft’s Health business. You can follow him on Twitter @chasedave. Imagine something so insidious that it leads to the following: over 750,000 personal bankruptcies per year. http://techcrunch.com/2011/06/19/the-most-important-organization-in-silicon-valley-that-no-one-has-heard-about/

The Rise of Nimble Medicine

http://techcrunch.com/2012/01/24/the-rise-of-nimble-medicine/ Editor’s note: This guest post was written by Dave Chase , the CEO of Avado.com , a patient portal & relationship management company that was a TechCrunch Disrupt finalist . Previously he was a management consultant for Accenture’s healthcare practice and founder of Microsoft’s Health platform business. You can follow him on Twitter @chasedave . Images are courtesy of Jason Hwang, M.D., M.B.A. Executive Director, Healthcare of the Innosight Institute and co-author of The Innovator’s Prescription.

Money Ball for Medicine – Business Models for Healthcare

Editor’s note: This guest post was written by Dave Chase , the CEO of Avado.com , a patient portal & relationship management company that was a TechCrunch Disrupt finalist . Previously he was a management consultant for Accenture’s healthcare practice and founder of Microsoft’s Health platform business. You can follow him on Twitter @chasedave . Entrepreneurial epiphanies surface in random places. For Eric Page, it was watching Brad Pitt’s latest movie, Moneyball. http://techcrunch.com/2012/01/17/money-ball-for-medicine-business-models-for-healthcare/
http://thehealthcareblog.com/blog/2012/02/03/nimble-medicine/

Nimble Medicine

By Dave Chase In a piece for the New Yorker, Dr. Atul Gawande outlined how, early in the 1900s, more than forty per cent of household income went to paying for food and food production consumed roughly half the workforce. Beginning in Texas, a wide array of new methods of food production were tested. After many pilots, tests and information dissemination, food now accounts for 8% of household budgets and 2% of the workforce.
http://techcrunch.com/2011/11/08/avado-launches-patient-relationship-management-platform-to-help-healthcare-providers-go-digital/

Avado Launches ‘Patient Relationship Management’ Platform To Help Healthcare Providers Go Digital

Back in May, Avado was chosen as a finalist at TechCrunch Disrupt in NYC. The startup’s ambition was, said in reductive terms, to become the Salesforce.com of personal health records. ( You can read our initial coverage here .) In other words, like Salesforce’s “customer relationship management” (CRM), Avado is building a “patient relationship management” (PRM) platform in an attempt to create a more fluid and communicative relationship between patients and doctors — by way of connected health records.
http://techcrunch.com/2011/07/23/healthcare-disruption-pharma-3-0-will-drive-shift-from-life-science-to-healthtech-investing-part-i-of-iii/

Healthcare Disruption: Pharma 3.0 Will Drive Shift from Life Science to HealthTech Investing (Part I of III)

Editor’s note: This guest post was written by Dave Chase, the CEO of Avado.com , a health technology company that was a TechCrunch Disrupt finalist . Previously he was a management consultant for Accenture’s healthcare practice and was the founder of Microsoft’s Health business. You can follow him on Twitter @chasedave . Healthcare’s hyperinflation is driving the transformation of how care gets reimbursed resulting in a massive disruption in healthcare.

Healthcare Disruption: Providers Will Use HealthTech to Differentiate and Produce Better Outcomes (Part II)

Editor’s note : This guest post was written by Dave Chase, the CEO of Avado.com , a health technology company that was a TechCrunch Disrupt finalist . Previously he was a management consultant for Accenture’s healthcare practice and was the founder of Microsoft’s Health business. You can follow him on Twitter @chasedave . Historically, in the U.S.
Editor’s note: This guest post was written by Dave Chase , the CEO of Avado.com , a health technology company that was a TechCrunch Disrupt finalist . Previously he was a management consultant for Accenture’s healthcare practice consulting to 25 hospitals and was the founder of Microsoft’s Health business. You can follow him on Twitter @chasedave . Since the latter half of the 90’s, the handwriting has been on the wall for newspaper companies that media’s future was digital. Heck, the newspapers’ own business sections reported on this trend.

Healthcare Disruption: Providers Are Making Newspaper Industry Mistakes (Part III)

By DAVE CHASE Recently ZocDoc had a huge funding round demonstrating the success that they are having. There’s a number of lessons learned from ZocDoc’s experience. Unfortunately, many haven’t demonstrated Zocdoc’s wisdom leading to a large number of healthtech failures. A recent study highlights this phenomena.

Lessons from the Carnage in HealthTech

What Pharma Can Learn From the Railroads and IBM

Editor’s note: This guest post was written by Dave Chase , the CEO of Avado.com , a patient portal & relationship management company that was a TechCrunch Disrupt finalist . Previously he was a management consultant for Accenture’s healthcare practice and founder of Microsoft’s Health platform business. You can follow him on Twitter @chasedave . Pharmaceutical companies are in trouble with ongoing patent cliffs with a clear choice facing them.